Moderna News - June 17, 2026
🟢 Moderna Inc makes sharp 10.1% jump
MRNA is trading at $61.02, up 10.1% versus the comparison close of $55.40 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 Moderna Inc extends move to 5.1% up
MRNA is trading at $58.22, up 5.1% versus the comparison close of $55.40 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 Moderna Inc is trading 4.15% up today on new operating model, 2027-2028 product launch outlook, and favorable FDA flu vaccine data
Moderna Inc is trading 4.15% up now at $57.70, extending a sharp multi-day rally as investors react to the company’s new operating model, leadership...
Moderna Restructures Leadership for Future Product Launches
Moderna changed its operating model. The company prepares for multiple product launches. These launches are anticipated in 2027 and 2028. President Dr....
Moderna flu shot clears FDA review, despite gaps in clinical data
FDA staff found no major deficiencies in Moderna’s experimental mRNA flu vaccine, mFlusiva (mRNA-1010). Briefing documents released ahead of a June 18...